Global Stomach Cancer Treatment Market Report

The global demand for Stomach Cancer Treatment Market is presumed to reach the market size of nearly USD 12.01 BN by 2028 from USD 4.83 BN in 2021 with a CAGR of 13.9% under the study period 2022 - 2028.

Stomach cancer has become one of the most common health issues in recent years, and one needs to go through several tests to find the best stomach cancer treatment, depending on the stage. The stage determines how curable a cancer is and the best treatment approach. The treatment options include surgery to remove cancer, chemotherapy, radiation, immunotherapy and targeted drugs. 

Market Dynamics 

Gastric cancer is one of the common problems causing cancer-related deaths worldwide. Due to the covid 19 pandemic, diagnosis delays have caused more cancer cases. Targeted drugs are now frequently used for stomach cancer treatment in countries like the US. On the other hand, developing countries like China and India prefer chemotherapy and surgery to remove cancer. However, the approval of targeted drug treatment is proliferating and is expected to become a primary treatment option.

The research report covers Porter's Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry's structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of stomach cancer treatment. The growth and trends of stomach cancer treatment industry provide a holistic approach to this study. 

Market Segmentation

This section of the stomach cancer treatment market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities. 

By Treatment Type

• Immunotherapy
• Targeted Therapy
• Chemotherapy
• Radiation Therapy And Surgery (Qualitative Analysis Only)

By Disease Indication

• Gastric Cancer/Gastroesophageal Junction Cancer
• Gastrointestinal Stromal Tumors

By Route Of Administration

• Oral
• Injectable

By Drug Class

• PD-1/PD-L1 Inhibitors
• HER2 Antagonists
• VEGFR2 Antagonists
• Others

By Distribution Channel

• Hospital Pharmacies
• Specialty & Retail Pharmacies
• Others

Regional Analysis

This section covers the regional outlook, which accentuates current and future demand for the Stomach Cancer Treatment market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.

Global Stomach Cancer Treatment Market Share by Region (Representative Graph)

The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the stomach cancer treatment market include Novartis AG, Pfizer, Inc., Mylan N.V., F. Hoffmann La Roche Ltd., Eli Lilly and Company, Merck & Co., Inc., Teva Pharmaceutical Industries Ltd., Celltrion Healthcare Co. Ltd, Samsung Bioepis, Bristol Myers Squibb Company. This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.